Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Frater

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalenceRebecca Payne, Maximilian Muenchhoff, Jaclyn Mann, et al.
Plos One|May 6, 2011
Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutationsKuan-Hsiang Gary Huang, Dominique Goedhals, Jonathan M Carlson, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Blood|December 21, 2012
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infectionCormac Cosgrove, James E Ussher, Andri Rauch, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Plos Pathogens|June 16, 2015
Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV InfectionEmily Adland, Paolo Paioni, Christina Thobakgale, et al.
JCI Insight|January 5, 2023
Slow progression of pediatric HIV associates with early CD8+ T cell PD-1 expression and a stem-like phenotypeVinicius Vieira, Nicholas Lim, Alveera Singh, et al.
Plos Pathogens|November 18, 2021
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adultsVinicius A Vieira, Emily Adland, David F G Malone, et al.
Lancet (London, England)|February 23, 2020
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trialSarah Fidler, Wolfgang Stöhr, Matt Pace, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalenceRebecca Payne, Maximilian Muenchhoff, Jaclyn Mann, et al.
Plos One|May 6, 2011
Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutationsKuan-Hsiang Gary Huang, Dominique Goedhals, Jonathan M Carlson, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Blood|December 21, 2012
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infectionCormac Cosgrove, James E Ussher, Andri Rauch, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Plos Pathogens|June 16, 2015
Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV InfectionEmily Adland, Paolo Paioni, Christina Thobakgale, et al.
JCI Insight|January 5, 2023
Slow progression of pediatric HIV associates with early CD8+ T cell PD-1 expression and a stem-like phenotypeVinicius Vieira, Nicholas Lim, Alveera Singh, et al.
Plos Pathogens|November 18, 2021
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adultsVinicius A Vieira, Emily Adland, David F G Malone, et al.
Lancet (London, England)|February 23, 2020
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trialSarah Fidler, Wolfgang Stöhr, Matt Pace, et al.
Pageof 12